Previous close | 9.60 |
Open | 9.60 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 40.00 |
Expiry date | 2026-01-16 |
Day's range | 9.60 - 9.60 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Investing.com -- As signs emerge that demand for GLP-1 drugs is stronger than expected, many are fearing the worst for packaged-food companies, but Bernstein believes that some companies are likely to fare better than others as patients on these weight-loss drugs shift appetite in favor of more protein-based foods.
CPB's focus on innovation, portfolio reshaping and maintaining affordability positions it well for growth. Yet, cost inflation and Snacks unit hurdles remain.
Retailers could face problems restocking hot sellers this holiday season.